Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 12, 2017 00:59 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA ANNOUNCES THREE OUTCOMES TRIALS IN HEART FAILURE AND IRON DEFICIENCY

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Further...
June 09, 2017 00:58 ET | Source: Vifor Pharma Ltd.

KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Kissei to have exclusive...
May 19, 2017 00:57 ET | Source: Vifor Pharma Ltd.

CHMP RECOMMENDS VELTASSA® FOR THE TREATMENT OF HYPERKALAEMIA IN THE EU

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Klicken Sie hier für...
May 16, 2017 00:58 ET | Source: Vifor Pharma Ltd.

Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...
May 11, 2017 11:34 ET | Source: Vifor Pharma Ltd.

89th Annual General Meeting of Galenica Ltd.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Klicken Sie hier für Deutsch ...
April 12, 2017 00:57 ET | Source: Vifor Pharma Ltd.

Galenica Santé IPO - Full exercise of over-allotment option

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Dear Madam/Sir, Today Galenica and...
April 07, 2017 01:06 ET | Source: Vifor Pharma Ltd.

Successful Galenica Santé IPO, Galenica Group becomes Vifor Pharma Group

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Dear Madam/Sir, Today Galenica and...
February 20, 2017 01:00 ET | Source: Vifor Pharma Ltd.

Vifor Pharma continues commitment to raise awareness of iron deficiency

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} The 12th ECCO Congress that took place...
February 14, 2017 01:00 ET | Source: Vifor Pharma Ltd.

Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ChemoCentryx retains all rights in the...
December 23, 2016 00:59 ET | Source: Vifor Pharma Ltd.

Vifor Pharma and ChemoCentryx Announce Expansion of Kidney Health Alliance to Include CCX140 to Treat Renal Diseases

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ChemoCentryx to retain...